Patents by Inventor Eli LEWIS

Eli LEWIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HANDHELD TAPE DISPENSER AND METHODS OF USE THEREOF
    Publication number: 20250368466
    Abstract: Disclosed herein is a tape dispenser system that includes a monolithic frame with clips that allow for rolls of tape to snap easily on and off the dispenser. The system includes a handle with divots that indicate the proper orientation for which a user should hole the tape dispenser while tearing the tape. The dispenser includes a tearing mechanism comprised of a single plastic point which punctures the tape easily without risking injury. The system disclosed herein is compact, lightweight and suitable for all users including children and adults with physical disabilities.
    Type: Application
    Filed: May 28, 2024
    Publication date: December 4, 2025
    Inventor: Eli LEWIS
  • ANTINECROTIC ACTIVITY OF ALPHA 1-ANTITRYPSIN
    Publication number: 20190307866
    Abstract: The present invention is related to the use of alpha-1-antitrypsin as an anti-necrotic agent. This invention provides a method for the treatment of tissue necrosis by administration of alpha-1-antitrypsin. This invention further provides methods for prophylactic treatment of tissue necrosis and for inhibition of tissue necrosis in culture by addition of alpha-1-antitrypsin.
    Type: Application
    Filed: June 17, 2019
    Publication date: October 10, 2019
    Inventors: Ilana Nathan, Eli Lewis, Boris Khalfin
  • Combined therapy of alpha-1-antitrypsin and temporal T-cell depletion for preventing graft rejection
    Patent number: 10086070
    Abstract: A method of preventing or treating xenotransplant rejection in a subject in need thereof is disclosed. The method comprises administering a therapeutically effective amount of alpha-1-antitrypsin (AAT) in combination with a therapeutically effective amount of an anti-CD8 antibody or an antigen binding fragment thereof.
    Type: Grant
    Filed: April 3, 2017
    Date of Patent: October 2, 2018
    Assignee: Ben Gurion University of the Neger Research and Development Authority
    Inventor: Eli Lewis
  • IL-1beta propeptide and IL-1Ra chimera and methods of using the same
    Patent number: 9895420
    Abstract: The present invention provides a chimera protein made of amino acid residues derived from IL-1beta propeptide and the IL-1Ra mature peptide and polynucleotides encoding the protein. The present invention also provides usages of the protein and the polynucleotides in pharmaceutical compositions that treat inflammation.
    Type: Grant
    Filed: June 5, 2014
    Date of Patent: February 20, 2018
    Assignees: B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN GURION UNIVERSITY, THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: Eli Lewis, Peleg Rider, Charles A. Dinarello
  • COMBINED THERAPY OF ALPHA-1-ANTITRYPSIN AND TEMPORAL T-CELL DEPLETION FOR PREVENTING GRAFT REJECTION
    Publication number: 20170202961
    Abstract: A method of preventing or treating xenotransplant rejection in a subject in need thereof is disclosed. The method comprises administering a therapeutically effective amount of alpha-1-antitrypsin (AAT) in combination with a therapeutically effective amount of an anti-CD8 antibody or an antigen binding fragment thereof.
    Type: Application
    Filed: April 3, 2017
    Publication date: July 20, 2017
    Inventor: Eli LEWIS
  • IL-1beta-IL-1Ra CHIMERA AND METHODS OF USING THE SAME
    Publication number: 20160220641
    Abstract: The present invention provides a chimera protein made of amino acid residues derived from IL-1beta propeptide and the IL-1Ra mature peptide and polynucleotides encoding the protein. The present invention also provides usages of the protein and the polynucleotides in pharmaceutical compositions that treat inflammation.
    Type: Application
    Filed: June 5, 2014
    Publication date: August 4, 2016
    Applicants: B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD. (BE N-GURION UNIVERSITY), THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: Eli Lewis, Peleg Rider, Charles A. Dinarello
  • COMBINED THERAPY OF ALPHA-1-ANTITRYPSIN AND TEMPORAL T-CELL DEPLETION FOR PREVENTING GRAFT REJECTION
    Publication number: 20150010581
    Abstract: The present invention provides compositions and methods for the prevention and treatment of aggressive immune processes to life-saving grafts, such as xenograft rejection, and for attenuating host responses in transplantation of tissues, cells and organs. More specifically, the compositions and methods of the present invention relate to combined therapies comprising treatment of alpha-1-antitrypsin (AAT) and temporary T-cell depletion including but not limited to anti-CD4 and anti-CD8 antibodies.
    Type: Application
    Filed: February 27, 2013
    Publication date: January 8, 2015
    Inventor: Eli Lewis
  • ANTINECROTIC ACTIVITY OF ALPHA 1-ANTITRYPSIN
    Publication number: 20110237496
    Abstract: The present invention is related to the use of alpha-1-antitrypsin as an anti-necrotic agent. This invention provides a method for the treatment of tissue necrosis by administration of alpha-1-antitrypsin. This invention further provides methods for prophylactic treatment of tissue necrosis and for inhibition of tissue necrosis in culture by addition of alpha-1-antitrypsin.
    Type: Application
    Filed: September 6, 2009
    Publication date: September 29, 2011
    Inventors: Ilana Nathan, Eli Lewis, Boris Khalfin
  • COMPOSITIONS, METHODS AND USES FOR TREATING DIABETES
    Publication number: 20110112017
    Abstract: Embodiments herein concern compositions and methods for treating diabetes in a subject.
    Type: Application
    Filed: June 11, 2010
    Publication date: May 12, 2011
    Inventors: Lee SHAPIRO, Charles A. DINARELLO, Eli LEWIS, Peter GOTTLIEB, Amy WALLACE, Aaron MICHELS, Gregory B. POTTS